1. Home
  2. PSNL vs ACCO Comparison

PSNL vs ACCO Comparison

Compare PSNL & ACCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • ACCO
  • Stock Information
  • Founded
  • PSNL 2011
  • ACCO 1893
  • Country
  • PSNL United States
  • ACCO United States
  • Employees
  • PSNL N/A
  • ACCO N/A
  • Industry
  • PSNL Medical Specialities
  • ACCO Publishing
  • Sector
  • PSNL Health Care
  • ACCO Consumer Discretionary
  • Exchange
  • PSNL Nasdaq
  • ACCO Nasdaq
  • Market Cap
  • PSNL 460.7M
  • ACCO 410.0M
  • IPO Year
  • PSNL 2019
  • ACCO N/A
  • Fundamental
  • Price
  • PSNL $3.62
  • ACCO $3.79
  • Analyst Decision
  • PSNL Strong Buy
  • ACCO Buy
  • Analyst Count
  • PSNL 5
  • ACCO 1
  • Target Price
  • PSNL $7.80
  • ACCO $7.00
  • AVG Volume (30 Days)
  • PSNL 708.2K
  • ACCO 836.8K
  • Earning Date
  • PSNL 05-07-2025
  • ACCO 05-01-2025
  • Dividend Yield
  • PSNL N/A
  • ACCO 7.96%
  • EPS Growth
  • PSNL N/A
  • ACCO N/A
  • EPS
  • PSNL N/A
  • ACCO N/A
  • Revenue
  • PSNL $84,614,000.00
  • ACCO $1,666,200,000.00
  • Revenue This Year
  • PSNL N/A
  • ACCO N/A
  • Revenue Next Year
  • PSNL $27.78
  • ACCO $1.07
  • P/E Ratio
  • PSNL N/A
  • ACCO N/A
  • Revenue Growth
  • PSNL 15.15
  • ACCO N/A
  • 52 Week Low
  • PSNL $1.14
  • ACCO $3.47
  • 52 Week High
  • PSNL $7.20
  • ACCO $6.44
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 54.93
  • ACCO 46.17
  • Support Level
  • PSNL $3.09
  • ACCO $3.50
  • Resistance Level
  • PSNL $3.33
  • ACCO $3.79
  • Average True Range (ATR)
  • PSNL 0.32
  • ACCO 0.20
  • MACD
  • PSNL 0.08
  • ACCO 0.03
  • Stochastic Oscillator
  • PSNL 94.30
  • ACCO 64.18

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. It offers its products under the AT-A-GLANCE, Five Star, GBC, Hilroy, Kensington, Quartet, Leitz, NOBO and other brands. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands North America segment.

Share on Social Networks: